MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $223 | $40 | $30 | $49 |
| Short-Term Investments | $169 | $185 | $211 | $213 |
| Receivables | $0 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $3 | $2 | $4 |
| Total Curr. Assets | $398 | $229 | $244 | $267 |
| Property Plant & Equip (Net) | $3 | $2 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $2 | $2 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $400 | $232 | $246 | $269 |
| Liabilities | – | – | – | – |
| Payables | $4 | $6 | $4 | $5 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $6 | $6 | $6 |
| Total Curr. Liab. | $12 | $12 | $10 | $11 |
| LT Debt | $0 | $1 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $1 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $0 | $0 |
| Total Liabilities | $13 | $12 | $11 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$202 | -$181 | -$161 | -$138 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $590 | $400 | $397 | $395 |
| Total Equity | $388 | $219 | $235 | $257 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $400 | $232 | $246 | $269 |
| Net Debt | -$223 | -$39 | -$30 | -$49 |